ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Alibaba Health Information Technology Limited Stock OTC Markets
Equities
ALBHF
BMG0171K1018
Drug Retailers
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.42 USD | +8.02% |
|
+2.44% | -22.29% |
| May. 28 | Hong Kong Stocks Stayed Flat Despite Shanghai’s Property Cuts, Beijing’s Huge Investment Plan | MT |
| May. 28 | Alibaba Health Shares Rise on Earnings Beat | DJ |
| Sales 2024 | 27.03B 3.73B | Sales 2025 * | 31.51B 4.35B | Capitalization | 50.42B 6.96B |
|---|---|---|---|---|---|
| Net income 2024 | 883M 122M | Net income 2025 * | 1.64B 227M | EV / Sales 2024 | 1.75 x |
| Net cash position 2024 * | 10.91B 1.51B | Net cash position 2025 * | 11.18B 1.54B | EV / Sales 2025 * | 1.25 x |
| P/E ratio 2024 |
46.8
x | P/E ratio 2025 * |
28.6
x | Employees | 1,435 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.22% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +8.02% | ||
| 1 week | +2.44% | ||
| Current month | +18.34% | ||
| 1 month | +19.83% | ||
| 3 months | -11.00% | ||
| 6 months | -27.44% | ||
| Current year | -22.29% |
1 week
0.38
0.42
1 month
0.340.42
Current year
0.320.54
1 year
0.320.72
3 years
0.322.62
5 years
0.324.01
10 years
0.324.01
| Managers | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 46 | - |
Yan Wu Tu
DFI | Director of Finance/CFO | 46 | 19-08-31 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yi Hong Wu
BRD | Director/Board Member | 56 | 23-08-10 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
Rong Shao
BRD | Director/Board Member | 62 | 23-08-10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 0.42 | +8.02% | 850 |
| 24-05-24 | 0.3888 | -0.43% | 1,289 |
| 24-05-22 | 0.3905 | -4.76% | 300 |
| 24-05-21 | 0.41 | -0.05% | 300 |
Delayed Quote OTC Markets, May 28, 2024 at 11:18 am EDT
More quotes
Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities:
- direct sale of pharmaceuticals (85.2%);
- online sale of pharmaceuticals(12.7%);
- direct healthcare services (1.8%);
- online healthcare services and monitoring of pharmaceuticals (0.3%).
The turnover is divided into the revenue sources of product sales (80.8%) and services (19.2%).
The geographical breakdown of the turnover is as follows: mainland China (95.8%) and Hong Kong (4.2%).
Sector
Drug Retailers
Calendar
2024-11-25
- Q2 2025 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
3.135
CNY
Average target price
5.146
CNY
Spread / Average Target
+64.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -41.10% | 13.27B | |
| -30.31% | 11.76B | |
| +14.31% | 6.38B | |
| -13.96% | 5.88B | |
| +72.00% | 4.98B | |
| -3.07% | 4.59B | |
| -6.07% | 3.98B | |
| -18.47% | 3.19B | |
| -13.85% | 2.83B |
- Stock Market
- Equities
- 241 Stock
- ALBHF Stock
